EUVIMEDEUVIMED entdecken
Leserbrief

Letter: LGP2 Q425R In Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Authors' Reply

Sara Cmet, Edmondo Falleti iD, Elisabetta Degasperi iD, Pietro Lampertico iD, Pierluigi Toniutto iD

Alimentary Pharmacology & Therapeutics · 03.11.2026

DOI: 10.1111/apt.71085 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 03.11.2026. Verfasst von Sara Cmet und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, University of Udine, Udine, Italy. Die Arbeit nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Hepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, University of Udine, Udine, Italy.
  • Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • CRC 'A. M. and A. Migliavacca' Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

ORCID-Profile: Edmondo Falleti, Elisabetta Degasperi, Pietro Lampertico, Pierluigi Toniutto

Zitieren

APA

Cmet, S., Falleti, E., Degasperi, E., Lampertico, P., & Toniutto, P. (2026). Letter: LGP2 Q425R In Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Authors' Reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71085

Vancouver

Cmet S, Falleti E, Degasperi E, Lampertico P, Toniutto P. Letter: LGP2 Q425R In Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71085

BibTeX
@article{Cmet2026,
  author = {Cmet, Sara and Falleti, Edmondo and Degasperi, Elisabetta and Lampertico, Pietro and Toniutto, Pierluigi},
  title = {Letter: LGP2 Q425R In Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.71085}
}
Kostenlos starten →